142 related articles for article (PubMed ID: 32232668)
1. Cancer Screening: No Longer the Default.
Hochman M; Cohen P
J Gen Intern Med; 2021 Feb; 36(2):525-526. PubMed ID: 32232668
[No Abstract] [Full Text] [Related]
2. In defense of screening for breast cancer with magnetic resonance imaging.
Keller DL
JAMA Intern Med; 2014 Aug; 174(8):1417. PubMed ID: 25090183
[No Abstract] [Full Text] [Related]
3. Abbreviated Magnetic Resonance Imaging for Breast Cancer Screening: Concept, Early Results, and Considerations.
Ko ES; Morris EA
Korean J Radiol; 2019 Apr; 20(4):533-541. PubMed ID: 30887736
[TBL] [Abstract][Full Text] [Related]
4. Screening for lung cancer: Does MRI have a role?
Biederer J; Ohno Y; Hatabu H; Schiebler ML; van Beek EJR; Vogel-Claussen J; Kauczor HU
Eur J Radiol; 2017 Jan; 86():353-360. PubMed ID: 27665148
[TBL] [Abstract][Full Text] [Related]
5. In defense of screening for breast cancer with magnetic resonance imaging--reply.
Hwang ES
JAMA Intern Med; 2014 Aug; 174(8):1417-8. PubMed ID: 25090184
[No Abstract] [Full Text] [Related]
6. Functional In Vivo Imaging of Tumors.
Haris M; Nisar S; Hashem S; Bhat AA; Yadav S; Shanmugakonar M; Al-Naemi H; Bagga P; Uddin S; Reddy R
Cancer Treat Res; 2020; 180():3-50. PubMed ID: 32215865
[TBL] [Abstract][Full Text] [Related]
7. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
[TBL] [Abstract][Full Text] [Related]
8. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.
Petralia G; Koh DM; Attariwala R; Busch JJ; Eeles R; Karow D; Lo GG; Messiou C; Sala E; Vargas HA; Zugni F; Padhani AR
Radiology; 2021 Jun; 299(3):494-507. PubMed ID: 33904776
[TBL] [Abstract][Full Text] [Related]
9. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.
Lee-Felker S
J Womens Health (Larchmt); 2018 Jun; 27(6):733-734. PubMed ID: 29437529
[No Abstract] [Full Text] [Related]
10. Magnetic resonance colonography for screening and diagnosis of colorectal cancer.
van der Paardt MP; Stoker J
Magn Reson Imaging Clin N Am; 2014 Feb; 22(1):67-83. PubMed ID: 24238133
[TBL] [Abstract][Full Text] [Related]
11. AI and imaging-based cancer screening: getting ready for prime time.
Kleeff J; Ronellenfitsch U
Nat Med; 2023 Dec; 29(12):3002-3003. PubMed ID: 37985691
[No Abstract] [Full Text] [Related]
12. Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI.
Greer MC; Voss SD; States LJ
Clin Cancer Res; 2017 Jun; 23(11):e6-e13. PubMed ID: 28572262
[TBL] [Abstract][Full Text] [Related]
13. Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
Jones TA; Marks LS
Eur Urol; 2017 Jun; 71(6):986-987. PubMed ID: 28233592
[No Abstract] [Full Text] [Related]
14. Investigating cancer patient acceptance of Whole Body MRI.
Oliveri S; Pricolo P; Pizzoli S; Faccio F; Lampis V; Summers P; Petralia G; Pravettoni G
Clin Imaging; 2018; 52():246-251. PubMed ID: 30170274
[TBL] [Abstract][Full Text] [Related]
15. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
[TBL] [Abstract][Full Text] [Related]
16. Screening in patients with increased risk of breast cancer (part 2). Where are we now? Actual MRI screening controversies.
Alonso Roca S; Delgado Laguna AB; Arantzeta Lexarreta J; Cajal Campo B; López Ruiz A
Radiologia (Engl Ed); 2020; 62(5):417-433. PubMed ID: 32527577
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening controversies: who, when, why, and how?
Chetlen A; Mack J; Chan T
Clin Imaging; 2016; 40(2):279-82. PubMed ID: 26093511
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological study on PET cancer screening].
Senda M; Inoue T; Uno K; Jinnouchi M; Tsukamoto E; Terauchi T; Nakajima R; Nishizawa S; Minamimoto R; Yoshida T
Kaku Igaku; 2009 Jun; 46(2):100-2. PubMed ID: 19791309
[No Abstract] [Full Text] [Related]
19. Breast screening with magnetic resonance imaging.
Scaranelo A
CMAJ; 2012 Nov; 184(16):E877. PubMed ID: 22802387
[No Abstract] [Full Text] [Related]
20. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
